Organization
Dr Reddy's Laboratories Ltd. ▼
Topic
All Topics ▼
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Dr Reddy's Laboratories Ltd.
Dr. Reddy's Laboratories Announces the Launch of Neostigmine Methylsulfate Injection, USP in the U.S. Market
September 12, 2018  •  Business Wire
... Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries ...
Global Biosimilar Market 2018-2023: Patent Expirees of Blockbuster Biological Drugs, Lower Prices, Rising Prevalence of Chronic Diseases, and Cost Saving Initiatives
September 7, 2018  •  PR Newswire
... research and development. Global Biosimilar Market Drivers/Constraints: 13.3.11 Boehringer Ingelheim 13.3.10 Dr. Reddy's Laboratories 13.3.9 Amgen 13.3.8 Biocon 13.3.7 Eli Lilly 13.3.6 Samsung Bioepis 13.3.5 ...
Judge Probes Mental State In Dr. Reddy's Manufacturing Suit
August 8, 2018  •  Law360
... PM EDT) -- A New Jersey federal judge expressed skepticism Wednesday over Dr. Reddy’s Laboratories Ltd.’s bid to toss a putative consolidated class action on ...
Dr. Reddy's Q1 FY19 Financial Results
July 26, 2018  •  Business Wire
... Dr. Reddy's Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY) today announced ...
Dr. Reddy's Laboratories Announces the Launch of Hervycta® (trastuzumab biosimilar) in India
July 26, 2018  •  Business Wire
... Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY) announced today that it has launched ...
Dr. Reddy's Announces the Launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg in the U.S. Market
July 20, 2018  •  Business Wire
... Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddys Laboratories Ltd. RDY
July 19, 2018  •  Legal Monitor Worldwide
... Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddys Laboratories Ltd. (Dr. Reddys or the Company) (NYSE:RDY). Such investors are advised to ...
Indivior buoyed after sales of rival opioid drug halted
July 17, 2018  •  The Daily Telegraph (London)
... on Friday granted Indivior a preliminary injunction which stops rival pharmaceutical company Dr Reddy's from selling a generic version of its Suboxone film, an opioid ...
US ruling relief for Indivior as shares recover
July 17, 2018  •  City A.M.
... the US. On Friday a court in New Jersey ruled that Dr Reddy's Laboratories (DRL) would have to stop selling the generic copy until litigation ...
Court Ruling in Favor of Aquestive Therapeutics Enjoining Dr. Reddy's Laboratories from Launching its Generic Suboxone Product
July 16, 2018  •  PR Newswire
... INDV) and its U.S. subsidiary, Indivior Inc., a preliminary injunction against Dr. Reddy's Laboratories ("DRL"), mandating the restrictions of the previously entered temporary restraining order ...
Related News Feeds
Board and Executive Moves involving Dr Reddy's Laboratories Ltd.
Pharmaceuticals
Board and Executive Moves in Pharmaceuticals
Alumni of Dr Reddy's Laboratories Ltd.
Subscribe now for full coverage on Dr Reddy's Laboratories Ltd.
Start My Free Trial